These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16405108)

  • 41. Marinobufagenin (MBG) suppression of ethanol-seeking behavior is associated with inhibition of brain cortex Na/K-ATPase in mice.
    Kashkin VA; Bagrov AY; Fedorova OV; Bagrov YY; Agalakova NI; Patkina NA; Zvartau EE
    Eur Neuropsychopharmacol; 2002 Jun; 12(3):217-23. PubMed ID: 12007673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats.
    Fedorova OV; Anderson DE; Bagrov AY
    Am J Hypertens; 1998 Jul; 11(7):796-802. PubMed ID: 9683040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sodium pump inhibition and regional expression of sodium pump alpha-isoforms in lens.
    Tao QF; Hollenberg NK; Graves SW
    Hypertension; 1999 Nov; 34(5):1168-74. PubMed ID: 10567200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A sensitive [Na,K]ATPase assay specific for inhibitors acting through the digitalis-binding site.
    Tao QF; Soszynski PA; Hollenberg NK; Graves SW
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):859-63. PubMed ID: 7564329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective inhibition of the cellular sodium pump by emicymarin and 14ß anhydroxy bufadienolides.
    Hilton PJ; McKinnon W; Gravett EC; Peron JM; Frampton CM; Nicholls MG; Lord G
    Steroids; 2010 Dec; 75(13-14):1137-45. PubMed ID: 20688094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of marinobufagenin on electrophysiological and contractile characteristics of the rat diaphragm].
    Krivoĭ II; Kravtsova VV; Prokof'ev AV; Vashchinkina EV; Kubasov IV; Drabkina TM
    Ross Fiziol Zh Im I M Sechenova; 2006 Dec; 92(12):1463-73. PubMed ID: 17523467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective ligands for Na
    Chakraborty D; Fedorova OV; Bagrov AY; Kaphzan H
    Neuropharmacology; 2017 May; 117():338-351. PubMed ID: 28232062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Competition of ethanol with endogenous digoxin-like natriuretic factor as a possible mechanism of addiction].
    Bagrov IaIu; Dmitrieva NI; Manusova NB
    Dokl Akad Nauk; 1996 May; 348(2):268-9. PubMed ID: 8924858
    [No Abstract]   [Full Text] [Related]  

  • 49. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.
    Bagrov AY; Shapiro JI; Fedorova OV
    Pharmacol Rev; 2009 Mar; 61(1):9-38. PubMed ID: 19325075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states.
    Gonick HC; Ding Y; Vaziri ND; Bagrov AY; Fedorova OV
    Clin Exp Hypertens; 1998; 20(5-6):617-27. PubMed ID: 9682918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
    Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
    Bagrov AY; Dmitrieva RI; Fedorova OV; Kazakov GP; Roukoyatkina NI; Shpen VM
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):982-90. PubMed ID: 8896650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of canrenone on the digitalis site of Na+/K(+)-ATPase in human placental membranes and in erythrocytes.
    Balzan S; Nicolini G; Bellitto L; Ghione S; Biver P; Montali U
    J Cardiovasc Pharmacol; 2003 Jul; 42(1):32-6. PubMed ID: 12827023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative Action of Cardiotonic Steroids on Intracellular Processes in Rat Cortical Neurons.
    Lopachev AV; Lopacheva OM; Nikiforova KA; Filimonov IS; Fedorova TN; Akkuratov EE
    Biochemistry (Mosc); 2018 Feb; 83(2):140-151. PubMed ID: 29618300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endogenous digitalis-like factors. An historical overview.
    Buckalew VM
    Front Biosci; 2005 Sep; 10():2325-34. PubMed ID: 15970498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiation between various types of inotropes through discovery of differences in their ability to detect isoforms of Na+/K(+)-ATPase.
    Repke KR; Megges R; Weiland J
    J Enzyme Inhib; 1997 Apr; 12(1):53-8. PubMed ID: 9204382
    [No Abstract]   [Full Text] [Related]  

  • 57. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Na+, K+-ATPase inhibitors down-regulate gene expression of the intracellular signaling protein 14-3-3 in rat lens.
    McGowan MH; Russell P; Carper DA; Lichtstein D
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1559-63. PubMed ID: 10336553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endogenous cardiac glycosidelike compounds.
    Kelly RA
    Hypertension; 1987 Nov; 10(5 Pt 2):I87-92. PubMed ID: 2824372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.